UEA-1 has also been used to significantly discriminate between patients with benign prostatic hyperplasia and bladder cancer due to its higher binding affinity for the fucosylated-glycoisoform of integrin alpha-3 present in the urine of bladder cancer patients [18]. This evidence concerns the gene ITGA3 and urinary bladder cancer.